Page 23 - JCBP-2-3

Journal of Clinical and
Basic Psychosomatics The antidepressant effect of ketamine

2022;23(8):643-652. 2023;37(8):784-794.
doi: 10.1080/15622975.2021.2020900 doi: 10.1177/02698811231189432
17. Siegel JS, Palanca BJA, Ances BM, et al. Prolonged ketamine 26. Nugent AC, Robinson SE, Coppola R, Zarate CA Jr.
infusion modulates limbic connectivity and induces Preliminary differences in resting state MEG functional
sustained remission of treatment-resistant depression. connectivity pre- and post-ketamine in major depressive
Psychopharmacology (Berl). 2021;238(4):1157-1169. disorder. Psychiatry Res Neuroimaging. 2016;254:56-66.
doi: 10.1007/s00213-021-05762-6 doi: 10.1016/j.pscychresns.2016.06.006
18. Evans JW, Szczepanik J, Brutsche N, Park LT, Nugent AC, 27. Chen MH, Chang WC, Lin WC, et al. Functional
Zarate CA Jr. Default mode connectivity in major depressive dysconnectivity of frontal cortex to striatum predicts
disorder measured Up to 10 Days after ketamine ketamine infusion response in treatment-resistant depression.
administration. Biol Psychiatry. 2018;84(8):582-590. Int J Neuropsychopharmacol. 2020;23(12):791-798.
doi: 10.1016/j.biopsych.2018.01.027 doi: 10.1093/ijnp/pyaa056
19. Chen MH, Lin WC, Tu PC, et al. Antidepressant and 28. Mkrtchian A, Evans JW, Kraus C, et al. Ketamine modulates
antisuicidal effects of ketamine on the functional fronto-striatal circuitry in depressed and healthy individuals.
connectivity of prefrontal cortex-related circuits in Mol Psychiatry. 2021;26(7):3292-3301.
treatment-resistant depression: A double-blind, placebo- doi: 10.1038/s41380-020-00878-1
controlled, randomized, longitudinal resting fMRI study.
J Affect Disord. 2019;259:15-20. 29. Snaith RP, Hamilton M, Morley S, Humayan A,
Hargreaves D, Trigwell P. A scale for the assessment of
doi: 10.1016/j.jad.2019.08.022
hedonic tone the Snaith-Hamilton Pleasure Scale. Br J
20. Vasavada MM, Loureiro J, Kubicki A, et al. Effects of serial Psychiatry. 1995;167(1):99-103.
ketamine infusions on corticolimbic functional connectivity
in major depression. Biol Psychiatry Cogn Neurosci doi: 10.1192/bjp.167.1.99
Neuroimaging. 2021;6(7):735-744. 30. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-item
Quick Inventory of Depressive Symptomatology (QIDS),
doi: 10.1016/j.bpsc.2020.06.015
clinician rating (QIDS-C), and self-report (QIDS-SR):
21. Abdallah CG, Dutta A, Averill CL, et al. Ketamine, but Not A psychometric evaluation in patients with chronic major
the NMDAR antagonist lanicemine, increases prefrontal depression. Biol Psychiatry. 2003;54(5):573-583.
global connectivity in depressed patients. Chronic Stress doi: 10.1016/s0006-3223(02)01866-8
(Thousand Oaks). 2018;2.
31. Rivas-Grajales AM, Salas R, Robinson ME, Qi K,
doi: 10.1177/2470547018796102
Murrough JW, Mathew SJ. Habenula connectivity and
22. Abdallah CG, Averill CL, Salas R, et al. Prefrontal intravenous ketamine in treatment-resistant depression. Int
connectivity and glutamate transmission: Relevance to J Neuropsychopharmacol. 2021;24(5):383-391.
depression pathophysiology and ketamine treatment. Biol
Psychiatry Cogn Neurosci Neuroimaging. 2017;2(7):566-574. doi: 10.1093/ijnp/pyaa089
32. Reed JL, Nugent AC, Furey ML, Szczepanik JE, Evans JW,
doi: 10.1016/j.bpsc.2017.04.006
Zarate CA Jr. Ketamine normalizes brain activity during
23. Gartner M, Aust S, Bajbouj M, et al. Functional emotionally valenced attentional processing in depression.
connectivity between prefrontal cortex and subgenual Neuroimage Clin. 2018;20:92-101.
cingulate predicts antidepressant effects of ketamine. Eur
Neuropsychopharmacol. 2019;29(4):501-508. doi: 10.1016/j.nicl.2018.07.006
33. Anijarv TE, Can AT, Gallay CC, et al. Spectral changes of
doi: 10.1016/j.euroneuro.2019.02.008
EEG following a 6-Week low-dose oral ketamine treatment
24. Nakamura T, Tomita M, Horikawa N, et al. Functional in adults with major depressive disorder and chronic
connectivity between the amygdala and subgenual suicidality. Int J Neuropsychopharmacol. 2023;26(4):259-267.
cingulate gyrus predicts the antidepressant effects of
ketamine in patients with treatment-resistant depression. doi: 10.1093/ijnp/pyad006
Neuropsychopharmacol Rep. 2021;41(2):168-178. 34. McMillan R, Sumner R, Forsyth A, et al. Simultaneous EEG/
fMRI recorded during ketamine infusion in patients with
doi: 10.1002/npr2.12165
major depressive disorder. Prog Neuropsychopharmacol Biol
25. Burrows M, Kotoula V, Dipasquale O, Stringaris A, Psychiatry. 2020;99:109838.
Mehta MA. Ketamine-induced changes in resting
state connectivity, 2 h after the drug administration in doi: 10.1016/j.pnpbp.2019.109838
patients with remitted depression. J Psychopharmacol. 35. Sumner RL, McMillan R, Spriggs MJ, et al. Ketamine

Volume 2 Issue 3 (2024) 10 doi: 10.36922/jcbp.2596